Partial Rebreathing in the Treatment of Migraine With Aura

NCT03472417 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2018-03-23

No results posted yet for this study

Summary

A study to test the efficacy of a partial rebreathing device in treating and/or preventing migraine pain

Conditions

  • Migraine With Aura

Interventions

DEVICE

Active partial rebreathing device

DEVICE

Dummy partial rebreathing device

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER
  • Rehaler

    collaborator INDUSTRY
  • University of Aarhus

    lead OTHER

Principal Investigators

  • Flemming W Bach, MD, PhD · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03472417 on ClinicalTrials.gov